GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Wiley  (2)
  • Liu, Dan  (2)
Material
Publisher
  • Wiley  (2)
Language
Years
Subjects(RVK)
  • 1
    In: Advanced Materials, Wiley
    Abstract: Insufficient activation of the stimulator of interferon genes (STING) signaling pathway and profoundly immunosuppressive microenvironment largely limits the effect of cancer immunotherapy. Herein, we exploited tumor microenvironment (TME)‐responsive nanoparticles (PMM NPs) that simultaneously harness STING and Toll‐like receptor 4 (TLR4) to augment STING activation via TLR4‐mediated nuclear factor‐kappa B signaling pathway stimulation, leading to the increased secretion of type I interferons (i.e., 4.0‐fold enhancement of IFN‐β) and pro‐inflammatory cytokines to promote a specific T cell immune response. Moreover, PMM NPs relieved the immunosuppression of the TME by decreasing the percentage of Tregs, and polarizing M2 macrophages to the M1 type, thus creating an immune‐supportive TME to unleash a cascade adaptive immune response. Combined with an anti‐PD‐1 antibody, synergistic efficacy was achieved in both inflamed colorectal cancer and non‐inflamed metastatic breast tumor models. Moreover, rechallenging tumor‐free animals with hypotonic cells induced complete tumor rejection, indicating the generation of systemic antitumor memory. These TME‐responsive nanoparticles may open a new avenue to achieve the spatiotemporal orchestration of STING activation, providing a promising clinical candidate for next‐generation cancer immunotherapy. This article is protected by copyright. All rights reserved
    Type of Medium: Online Resource
    ISSN: 0935-9648 , 1521-4095
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 1474949-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Advanced Materials, Wiley, Vol. 36, No. 21 ( 2024-05)
    Abstract: Immunotherapy represents a revolutionary paradigm in cancer management, showcasing its potential to impede tumor metastasis and recurrence. Nonetheless, challenges including limited therapeutic efficacy and severe immune‐related side effects are frequently encountered, especially in solid tumors. Hydrogels, a class of versatile materials featuring well‐hydrated structures widely used in biomedicine, offer a promising platform for encapsulating and releasing small molecule drugs, biomacromolecules, and cells in a controlled manner. Immunomodulatory hydrogels present a unique capability for augmenting immune activation and mitigating systemic toxicity through encapsulation of multiple components and localized administration. Notably, hydrogels based on biopolymers have gained significant interest owing to their biocompatibility, environmental friendliness, and ease of production. This review delves into the recent advances in bio‐based hydrogels in cancer immunotherapy and synergistic combinatorial approaches, highlighting their diverse applications. It is anticipated that this review will guide the rational design of hydrogels in the field of cancer immunotherapy, fostering clinical translation and ultimately benefiting patients.
    Type of Medium: Online Resource
    ISSN: 0935-9648 , 1521-4095
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2024
    detail.hit.zdb_id: 1474949-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...